32 -12 (86) 2025 - Abdikarimov X.G., Gafur-Axunov M.A. - EPIDEMIOLOGY OF BONE MALIGNANT TUMORS IN THE REPUBLIC

EPIDEMIOLOGY OF BONE MALIGNANT TUMORS IN THE REPUBLIC

Abdikarimov X.G. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Gafur-Axunov M.A. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Nasirov S.K. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Davletov R.R. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Nurjabov A.I. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Asameddinov N.K. - Republic of specialized oncology and radiology Scientific and practical medical center Uzbekistan

Resume

The index of the dynamics of morbidity and mortality from malignant bone neoplasms in the Republic of Uzbekistan was carried out in this study. Based on data from the State Cancer Register, it was established that more than 25,000 new cases of malignant tumors were registered annually in the country, of which about 320 cases (1.3%) are tumors of bone tissue. Over the past decade, a steady downward trend has been observed in both the absolute number of cases and in morbidity and mortality rates per 100,000 population among both men and women. The largest proportion of patients with malignant bone tumors belongs to the 20–44-year old age group. About 3,000 patients with this diagnosis are currently under dispensary observation in Uzbekistan. The results obtained indicate a decrease in the prevalence and lethality of malignant bone tumors during the study period. At the same time, significant age-related differences in the structure of oncological morbidity were revealed, which requires further in-depth study of risk factors and improvement of preventive measures.

Keywords: malignant bone tumor, morbidity, mortality, epidemiology.

First page

187

Last page

194

For citation:Abdikarimov X.G., Gafur-Axunov M.A., Nasirov S.K., Davletov R.R., Nurjabov A.I., Asameddinov N.K. - EPIDEMIOLOGY OF BONE MALIGNANT TUMORS IN THE REPUBLIC//New Day in Medicine 12(86)2025 187-194 https://newdayworldmedicine.com/en/new_day_medicine/12-86-2025

List of References

  1. O‘zbekiston Respublikasi SSV davlat idoraviy hisobot shakllari “Yomon sifatli o‘simtalar bilan kasallanish to‘g‘risida ma’lumotlar” – 7-shakl, 2016–2024-yillar.
  2. Valiev A.K., Tararykova A.A., Teplyakov V.V., Musaev E.R., Rogozhin D.V., Sushentsov E.A. va boshqalar. Suyaklarning yomon sifatli o‘simtalarini dorivor davolash bo‘yicha amaliy tavsiyalar. RUSSCO amaliy tavsiyalari, 1-qism. Yomon sifatli o‘simtalar, 2023 (jild 13), 3s2, b. 335–355.
  3. Valiev A.K., Tararykova A.A., Teplyakov V.V., Musaev E.R., Rogozhin D.V., Sushentsov E.A., Machak G.N., Konev A.A., Fedorova A.V., Fedoseenko D.I. Birlamchi yomon sifatli suyak o‘simtalari. Yomon sifatli o‘simtalar. 2024;14(3s2-2):367-392. https://doi.org/10.18027/2224-5057-2024-14-3s2-1.2-14
  4. Merabishvili V.M., Chepik O.F., Merabishvili E.N. Suyaklarning yomon sifatli o‘simtalari. Kasallanish, o‘lim, hisob-kitobning ishonchliligi, gistoanatomik shakllar hisobga olingan bemorlarning omon qolishi // Sibir onkologik jurnali. 2015. №3. URL: https://cyberleninka.ru/article/n/zlokachestvennye-novoobrazovaniya-kostey-zabolevaemost-smertnost-dostovernost-ucheta-vyzhivaemost-bolnyh-s-uchetom-gistologicheskih (kirish sanasi: 01.07.2025).
  5. Basu M.A., Chawla S.P. Suyakning gigant hujayrali o‘simtasi: yangilangan ma’lumot. Curr Oncol Rep. 2021;23:51.
  6. Bielack S.S., Blattmann C., Borkhardt A. va boshqalar. Osteosarkoma va o‘lim sabablari: hamkor osteosarkoma tadqiqot guruhi (COSS)dagi 1520 vafot etgan bemorlarning hisobotlari. Eur J Cancer. 2022;176:50–57.
  7. Choi J.H., Ro J.Y. 2020-yilgi WHO suyak o‘simtalarini tasnifi: yangilangan sharh. Adv Anat Pathol. 2021;28:119–138.
  8. Cole S., Gianferante D.M., Zhu B., Mirabello L. Osteosarkoma: 1975–2017-yillar oralig‘ida SEER ma’lumotlar bazasi asosida kuzatuv, epidemiologiya va yakuniy natijalar tahlili. Cancer. 2022;128:2107–2118.
  9. Franchi A. Suyak o‘simtalarining epidemiologiyasi va tasnifi. Clin Cases Miner Bone Metab. 2012 May;9(2):92–95. Epub 2012 Sep 30. PMID: 23087718; PMCID: PMC3476517.
  10. Klangjorhor J., Pongnikorn D., Phanphaisarn A. va boshqalar. Tailandda suyak sarkomasi bilan kasallangan bemorlar orasida kasallanish va omon qolish ko‘rsatkichlari tahlili: 2001–2015-yillar populyatsiyaga asoslangan saraton registrlari hisobotlari. Cancer Epidemiol. 2022;76:102056.
  11. Mirzaei S., Saghari S., Bassiri F., Raesi R., Zarrabi A., Hushmandi K., Sethi G., Tergaonkar V. NF-κB saraton metastazi va davolashga javobning regulyatori sifatida: epitelial-mezenximal o‘tishga e’tibor. J Cell Physiol. 2022;237(7):2770–2795.
  12. National Comprehensive Cancer Network. NCCN Guidelines. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1418
  13. Viale P.H. American Cancer Society faktlari va raqamlar: 2020 nashri. J Adv Practitioner Oncol. 2020;11(2):135.
  14. Xu Y., Shi F., Zhang Y., Yin M., Han X., Feng J., Wang G. Yomon sifatli suyak o‘simtalari bilan bemorlarning 20 yillik kasallanish, yangi holatlar, o‘lim va omon qolish natijalari. Int J Cancer. 2024;154(2):226–240.
  15. Yu K., Chen Y., Tian Y., Kang H., Song K., Dong Y., Peng R., Li F. Birlamchi yomon sifatli suyak o‘simtalari bilan bemorlar orasida o‘limga olib keluvchi pnevmoniya xususiyatlari, kasallanish va xavf omillari: SEER ma’lumotlar bazasiga asoslangan kuzatuvchi tadqiqot. Transl Cancer Res. 2021;10(8):3659.

    file

    download